penicillamine has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The recent outbreak of severe acute respiratory syndrome (SARS) warrants the search for effective antiviral agents to treat the disease." | 1.32 | Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound. ( Chen, L; Hedenstierna, G; Keyaerts, E; Maes, P; Van Ranst, M; Vijgen, L, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keyaerts, E | 1 |
| Vijgen, L | 1 |
| Chen, L | 1 |
| Maes, P | 1 |
| Hedenstierna, G | 1 |
| Van Ranst, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Use of Tadalafil in Confirmed COVID-19 Pneumonia.[NCT04946162] | Phase 4 | 0 participants (Actual) | Interventional | 2020-04-20 | Withdrawn (stopped due to The investigators never completed the IRB application due to decrease in need to conduct the study.) | ||
| Expanded Access: Pulsed, Inhaled Nitric Oxide (iNO) for the Treatment of Patients With Mild or Moderate Coronavirus Disease (COVID-19)[NCT04358588] | 0 participants | Expanded Access | No longer available | ||||
| Nitric Oxide Gas Inhalation Therapy for Severe Acute Respiratory Syndrome Due to COVID-19.[NCT04290871] | Phase 2 | 0 participants (Actual) | Interventional | 2023-01-16 | Withdrawn (stopped due to The study will start to enroll patients soon) | ||
| Inhaled NO ReDuce postoperatIve pulmoNAry complicATions in patiEnts With Recent COVID-19 Infection[NCT05721144] | Phase 2 | 660 participants (Anticipated) | Interventional | 2023-02-17 | Recruiting | ||
| Nitric Oxide Gas Inhalation for Prevention of COVID-19 in Healthcare Providers[NCT04312243] | Phase 2 | 24 participants (Actual) | Interventional | 2020-04-07 | Active, not recruiting | ||
| Nitric Oxide Gas Inhalation Therapy in Spontaneous Breathing Patients With Mild/Moderate COVID19 Infection: a Randomized Clinical Trial[NCT04290858] | Phase 2 | 0 participants (Actual) | Interventional | 2020-03-01 | Withdrawn (stopped due to New coordinating center has been defined (Massachusetts General Hospital)) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for penicillamine and Respiratory Syndrome, Acute, Severe
| Article | Year |
|---|---|
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Topics: Animals; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Nitric Oxide Donors; Nitroprusside; Pen | 2004 |